Angiotensin IV is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-10-06. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
| Property | Value | Notes |
|---|---|---|
| Primary reported target | Hepatocyte growth factor/c-Met signaling | Findings mainly from cell and animal studies. |
| Related endogenous peptide | Angiotensin IV | Dihexa is described as a stabilized analog. |
| Common analytical method | Reverse-phase high-performance liquid chromatography | Used for purity assessment. |
| Identity confirmation | Mass spectrometry | Provides a molecular mass check. |
| Regulatory status | Not approved for human use | Sold as a research chemical in many jurisdictions. |
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.
Identity checks for dihexa usually rely on mass spectrometry and chromatographic purity analysis. A lyophilized powder is the common supplied form, and it may appear as a white to off-white solid. Aqueous solubility is limited, so laboratory work often uses an organic solvent such as dimethyl sulfoxide to prepare stock solutions. Because the peptide is not a standard pharmaceutical product, exact specifications can vary between suppliers. Certificates of analysis may accompany a batch, but they are not equivalent to regulatory approval.
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
== Mechanisms of hepatotoxicity == Since the withdrawal in 2000, mechanisms of troglitazone hepatotoxicity have been extensively studied using a variety of in vivo, in vitro, and computational methods. These studies have suggested that hepatotoxicity of troglitazone results from a combination of metabolic and nonmetabolic factors. The nonmetabolic toxicity is a complex function of drug-protein interactions in the liver and biliary system. Initially, the metabolic toxicity was largely associated with reactive metabolite formation from the thiazolidinedione and chromane rings of troglitazone. Moreover, the formation of quinone and o-quinone methide reactive metabolites were proposed to be formed by metabolic oxidation of the hydroxy group (OH group) of the chromane ring. Detailed quantum chemical analysis of the metabolic pathways for troglitazone has shown that quinone reactive metabolite is generated by oxidation of the OH group, but o-quinone methide reactive metabolite is formed by the oxidation of the methyl groups (CH3 groups) ortho to the OH group of the chromane ring. This understanding has been recently used in the design of novel troglitazone derivatives with antiproliferative activity in breast cancer cell lines.
Metabolic intermediates are compounds produced during the conversion of substrates (starting molecules) into final products in biochemical reactions within cells. Although these intermediates are of relatively minor direct importance to cellular function, they can play important roles in the allosteric regulation of enzymes, glycolysis, the citric acid cycle, and amino acid synthesis. Metabolic pathways consist of a series of enzymatically catalyzed reactions where each step transforms a substrate into a product that serves as the substrate for the next reaction. Metabolic intermediates are compounds that form during these steps, and they are neither the starting substrate nor the final product of the pathway. These intermediates are crucial because they allow for regulation, energy storage, and extraction of chemical energy in a controlled manner.
2 [Fe(EDTA)]− + H2S → 2 [Fe(EDTA)]2− + S + 2 H+ In this application, the iron(III) centre is reduced to its iron(II) derivative, which can then be reoxidised by air. In a similar manner, nitrogen oxides are removed from gas streams using [Fe(EDTA)]2−.
==== United Kingdom ==== The UK National Health Service (NHS) recommends that people at risk of vitamin D deficiency, breast-fed babies, formula-fed babies taking no more than 500 ml of infant formula a day, and children aged 6 months to 4 years, should take daily vitamin D supplements throughout the year to ensure sufficient intake. This includes people with limited skin synthesis of vitamin D, who are not often outdoors, are frail, housebound, living in a care home, or usually wearing clothes that cover up most of the skin, or with dark skin, such as having an African, African-Caribbean or south Asian background. Other people may be able to make adequate vitamin D from sunlight exposure from April to September. The NHS and Public Health England recommend that everyone, including those who are pregnant and breastfeeding, consider taking a daily supplement containing 10 μg (400 IU) of vitamin D during autumn and winter because of inadequate sunlight for vitamin D synthesis.
== Medical uses == Uses include for fungal infections of the foot, impetigo, pemphigus, superficial wounds, dermatitis (eczema), and tropical ulcers. Typically it is used in skin conditions that produce a lot of liquid. For tropical ulcers it is used together with procaine benzylpenicillin for two to four weeks. It can be used in children and adults. It can be applied as a soaked dressing or a bath. Petroleum jelly may be used on the nails before soaking to prevent their discoloration. The U.S. Food and Drug Administration does not recommend its use in either the crystal or tablet form.
Sources: en.wikipedia.org
Seaspeed began operating from Dover's Eastern Docks in 1968. British Rail built a new hoverport at the Western Docks, which opened for service in July 1978 (costing some £14 million compared to the original estimate of £8 million). The aim was twofold; one, to cater for the increase in the fleet capacity to four, with the prospect of two new French hovercraft entering the fleet, as well as to handle additional passenger volumes via the extended SR.N4s. Seaspeed would thus be able to compete with Hoverlloyd's operations in Pegwell Bay. two, to provide a direct rail link to London and attract business class professionals, a rail connection was envisaged, similar to that at Boulogne (Le Portel) Hoverport which had been developed in 1968. In the event, only one of the French vessels was deemed fit for purpose and it retired early in 1983, plagued by malfunctions and limitations. Moreover, the direct rail link via Dover Western Docks never materialised and a bus service ran to and from the station instead. The terminal was officially opened by the Duke of Kent in September 1981. After the closure of Hoverspeed in 2005, the Dover Hoverport remained unused. In February 2007, SpeedFerries signed a lease on the former Dover Hoverport, though not the terminal building, moving there from the Eastern Docks. SpeedFerries went into administration in November 2008, which saw the cessation of services to Boulogne. The hoverport site was redeveloped in 2009.
== Dalgona == Dalgona is a traditional Korean hard candy made with sugar and baking soda. But for Dalgona coffee, instead of putting hard formation candy into the coffee, make a whipped cream foam with Americano and sugar. Then put the Dalgona cream on top of the milk of your choice. Dalgona coffee was newly invented during the COVID-19 pandemic. The reason Dalgona coffee got viral during that period was due to the pandemic; people were in a situation where they had to stay home for safety. The regulation of the pandemic was when the COVID-19 test results came out to be positive, people had to quarantine for 14 days. With this background situation, people kept searching for things that they could stay active and productive during the time they stay home. The process of making Dalgona coffee was perfect for people. To make Dalgona whip cream, at least 400 times or more stirring process is needed. It's hard to make, but it was a creative and innovative taste of coffee at that time because people could make 'coffee shop' coffee at home. People started to post themselves making Dalgona coffee and this became some sort of trend 'Dalgona coffee challenge' and it spread through social media such as Google, Instagram, TikTok and YouTube. It went viral not only in Korea but also it went widespread all over the world included not only the Asia but also Central and South America. Even after the pandemic ended, lots of coffee shops in Korea launched Dalgona coffee as one of the new menu items. One of the popular coffee chain, Ediya coffee launched 'Dalgona latte' in May 2020.
=== EC 2.8.3: CoA-transferases === EC 2.8.3.1: propionate CoA-transferase EC 2.8.3.2: oxalate CoA-transferase EC 2.8.3.3: malonate CoA-transferase EC 2.8.3.4: deleted EC 2.8.3.5: 3-oxoacid CoA-transferase EC 2.8.3.6: 3-oxoadipate CoA-transferase EC 2.8.3.7: The activity is due to two enzymes, EC 2.8.3.22, succinyl-CoA—L-malate CoA-transferase and EC 2.8.3.20, succinyl-CoA—Dcitramalate CoA-transferase EC 2.8.3.8: acetate CoA-transferase EC 2.8.3.9: butyrate—acetoacetate CoA-transferase EC 2.8.3.10: citrate CoA-transferase EC 2.8.3.11: citramalate CoA-transferase EC 2.8.3.12: glutaconate CoA-transferase EC 2.8.3.13: succinate—hydroxymethylglutarate CoA-transferase EC 2.8.3.14: 5-hydroxypentanoate CoA-transferase EC 2.8.3.15: succinyl-CoA:(R)-benzylsuccinate CoA-transferase EC 2.8.3.16: formyl-CoA transferase EC 2.8.3.17: cinnamoyl-CoA:phenyllactate CoA-transferase EC 2.8.3.18: succinyl-CoA:acetate CoA-transferase EC 2.8.3.19: CoA:oxalate CoA-transferase EC 2.8.3.20: succinyl-CoA—D-citramalate CoA-transferase EC 2.8.3.21: L-carnitine CoA-transferase EC 2.8.3.22: succinyl-CoA—L-malate CoA-transferase EC 2.8.3.23: caffeate CoA-transferase EC 2.8.3.24: (''R'')-2-hydroxy-4-methylpentanoate CoA-transferase EC 2.8.3.25: bile acid CoA-transferase EC 2.8.3.26: succinyl-CoA:mesaconate CoA transferase
Because of this fact, it has become common practice to establish the quality of NMR ensembles, by comparing it against the unique conformation determined by X-ray diffraction, for the same protein. However, the X-ray diffraction structure may not exist, and, since the proteins in solution are flexible molecules, a protein represented by a single structure may lead to underestimate the intrinsic variation of the atomic positions of a protein. A set of conformations, determined by NMR or X-ray crystallography may be a better representation of the experimental data of a protein than a unique conformation. The utility of a model will be given, at least in part, by the degree of accuracy and precision of the model. An accurate model with relatively poor precision could be useful to study the evolutionary relationships between the structures of a set of proteins, whereas the rational drug design requires both precise and accurate models. A model that is not accurate, regardless of the degree of precision with which it was obtained will not be very useful. Since protein structures are experimental models that can contain errors, it is very important to be able to detect these errors. The process aimed at the detection of errors is known as validation. There are several methods to validate structures, some are statistical like PROCHECK and WHAT IF while others are based on physical principles as CheShift, or a mixture of statistical and physics principles PSVS.
Dinosterol has been used as an indicator for dinoflagellate production in the Cariaco Basin. In such studies, it has been revealed that the accumulation of dinosterol peaks at a rate of almost 900 mg compound/cm2/yr during the Younger Dryas. Hydrogen isotope ratios in dinosterols can serve to reconstruct salinity semi-quantitatively. Some studies have revealed that certain dinoflagellates produce sterols that have the potential to serve as genera-specific biomarkers. Recent work showed that dinoflagellate genera, which formed discrete clusters in the 18S rDNA-based phylogeny, shared similar sterol compositions. This suggested that the sterol compositions of dinoflagellates are explained by the evolutionary history of this lineage.
Sources: en.wikipedia.org
For services to Animal Health and voluntary service to Sport. Madeleine Clare Hinch, MBE. For services to Hockey. Elaine Hinchliffe-Dale (Elaine Dale). Director, Special Educational Needs and Disabilities Support, City College Norwich. For services to Further Education. Dr. Elizabeth Janine Hogben. Lately Secretary, Prime Minister's Council for Science and Technology, Government Office for Science. For services to Science in Government. Lady (Patricia Ann) Hopkins. For services to Architecture. Carol Wai Wing Hui. Lately Board Member, British Tourist Authority. For services to Tourism. Mahboob Hussain, JP. For services to the community in Buckinghamshire. Elizabeth Louise Hutton. Chief Executive Officer, Kicks Count. For services to Education and Prevention of Stillbirths. Alasdair Bruce Jackson. Chief Executive, Recycling Lives Charity. For services to the Rehabilitation of Offenders. Kerry Joanne Jackson. Chief Executive, St Gemma's Hospice. For services to Palliative and End of Life Care. Salim Hassanali Moledina Janmohamed. For charitable and voluntary services to Faith Communities. Peter Jefferies. Team Leader, Ministry of Defence. For services to Defence. Timothy Nigel Jenkins. Lately District Judge, Brentford County Court. For services to the Administration of Justice. Peter Sinclair Jensen. Lately Chair of Trustees, Home of Horseracing Trust and Chair, British Sporting Arts Trust. For Charitable Service. Dr. Christopher Paul Johnson. Forensic Pathologist, Home Office. For services to Criminal Justice. Christopher Jolly. Publisher, Jolly Phonics.
Susan Weintraub is an American scientist. She is a professor at the University of Texas Health Science Center at San Antonio (UTHSCSA). She received a BS in chemistry from the University of Pennsylvania in 1967, MS in chemistry from Trinity University in 1970 and a PhD in biochemistry from UTHSCSA in 1979. She was the president of the American Society for Mass Spectrometry for the period of 2012-2014. In 2017 she was named a Fellow of the American Association for the Advancement of Science (AAAS), and Fellow of the American Society for Mass Spectrometry in 2025. She is an associate editor of the Journal of Proteome Research. Her research focuses on biomedical mass spectrometry where she used mass spectrometry in the early 1970s for quantitative analysis of brain neurochemicals. She has been director of the mass spectrometry core resource at UTHSCSA since 1979.
An ACS program chair, Gopal Coimbatore, said that without a proper forum the matter would never be discussed and, "with the world facing an energy crisis, it is worth exploring all possibilities." On 22–25 March 2009, the American Chemical Society meeting included a four-day symposium in conjunction with the 20th anniversary of the announcement of cold fusion. Researchers working at the U.S. Navy's Space and Naval Warfare Systems Center (SPAWAR) reported detection of energetic neutrons using a heavy water electrolysis setup and a CR-39 detector, a result previously published in Naturwissenschaften. The authors claim that these neutrons are indicative of nuclear reactions. Without quantitative analysis of the number, energy, and timing of the neutrons and exclusion of other potential sources, this interpretation is unlikely to find acceptance by the wider scientific community.
With a budget of $103 million, the film was the most expensive Scorsese had ever made. DiCaprio was drawn to playing Amsterdam Vallon, the young leader of an Irish-American street gang, as it marked a shift from "boyish" roles to a mature leading man. Gangs of New York earned $193 million worldwide and received positive critical response. Anne Thompson of The Observer took note of DiCaprio's "low-key, sturdy performance", but felt that co-star Daniel Day-Lewis overshadowed him. In 2004, DiCaprio founded the production company Appian Way Productions, a namesake of the Italian road. He was interested in finding unique source material and preserving its essence during development, citing previous experiences where the involvement of too many people influenced the final product in a negative way. DiCaprio first executive-produced The Assassination of Richard Nixon, which starred Sean Penn as Samuel Byck, and was screened at the 2004 Cannes Film Festival. DiCaprio and Scorsese reunited for a biopic of Howard Hughes, an American film director and aviation pioneer suffering from obsessive–compulsive disorder, in The Aviator (2004), which DiCaprio also co-produced under Appian Way. He initially developed the project with Michael Mann who was eventually replaced by Scorsese. The Aviator became a critical and financial success, grossing $213 million against its budget of $110 million. Simond Braund of Empire thought DiCaprio convincingly played a complex role and highlighted the scenes depicting Hughes's paranoia and obsession.
Sources: en.wikipedia.org
Dihexa has been reported to activate hepatocyte growth factor/c-Met signaling in cell studies. This pathway is linked to synapse formation and neuronal remodeling. The exact molecular interactions are not fully understood.
Reverse-phase high-performance liquid chromatography is commonly used to assess purity. Mass spectrometry is used to confirm molecular identity. These methods are typical for synthetic peptides and research chemicals.
Dihexa is not approved as a drug in major jurisdictions. It is often sold as a research chemical, which is not the same as a medicine. Its legal status can vary by country and may change.
It is thought to enhance hepatocyte growth factor signaling through the c-Met receptor. This pathway is involved in cell growth and repair. The precise molecular details are not fully established.